Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5WIG

Structure of New Delhi Metallo-Beta-lactamase 4 (NDM-4)

5WIG の概要
エントリーDOI10.2210/pdb5wig/pdb
分子名称NDM-4, ZINC ION (3 entities in total)
機能のキーワードlactamase, hydrolase
由来する生物種Klebsiella pneumoniae
タンパク質・核酸の鎖数2
化学式量合計48866.36
構造登録者
VanPelt, J.,Williams, C.,Page, R.C. (登録日: 2017-07-19, 公開日: 2017-10-18, 最終更新日: 2023-10-04)
主引用文献Stewart, A.C.,Bethel, C.R.,VanPelt, J.,Bergstrom, A.,Cheng, Z.,Miller, C.G.,Williams, C.,Poth, R.,Morris, M.,Lahey, O.,Nix, J.C.,Tierney, D.L.,Page, R.C.,Crowder, M.W.,Bonomo, R.A.,Fast, W.
Clinical Variants of New Delhi Metallo-beta-Lactamase Are Evolving To Overcome Zinc Scarcity.
Acs Infect Dis., 3:927-940, 2017
Cited by
PubMed Abstract: Use and misuse of antibiotics have driven the evolution of serine β-lactamases to better recognize new generations of β-lactam drugs, but the selective pressures driving evolution of metallo-β-lactamases are less clear. Here, we present evidence that New Delhi metallo-β-lactamase (NDM) is evolving to overcome the selective pressure of zinc(II) scarcity. Studies of NDM-1, NDM-4 (M154L), and NDM-12 (M154L, G222D) demonstrate that the point mutant M154L, contained in 50% of clinical NDM variants, selectively enhances resistance to the penam ampicillin at low zinc(II) concentrations relevant to infection sites. Each of the clinical variants is shown to be progressively more thermostable and to bind zinc(II) more tightly than NDM-1, but a selective enhancement of penam turnover at low zinc(II) concentrations indicates that most of the improvement derives from catalysis rather than stability. X-ray crystallography of NDM-4 and NDM-12, as well as bioinorganic spectroscopy of dizinc(II), zinc(II)/cobalt(II), and dicobalt(II) metalloforms probe the mechanism of enhanced resistance and reveal perturbations of the dinuclear metal cluster that underlie improved catalysis. These studies support the proposal that zinc(II) scarcity, rather than changes in antibiotic structure, is driving the evolution of new NDM variants in clinical settings.
PubMed: 28965402
DOI: 10.1021/acsinfecdis.7b00128
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.4 Å)
構造検証レポート
Validation report summary of 5wig
検証レポート(詳細版)ダウンロードをダウンロード

246905

件を2025-12-31に公開中

PDB statisticsPDBj update infoContact PDBjnumon